English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Study finds walking patterns may help distinguish Lewy body dementia from Parkinson’s disease
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Gilead announces $2.1 billion acquisition of Ouro Medicines and other industry updates
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

UCB announces $2 billion biologics manufacturing facility in Georgia
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

RA Capital Management launches new SPAC with focus on Chinese biotech startups
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Merck to acquire Terns Pharmaceuticals and leukemia drug for $6.7 billion
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Trace Neuroscience pursues new ALS treatment targeting UNC13A protein deficiency
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Novo Nordisk's oral Wegovy launch draws attention as access barriers persist for obesity drugs
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Karyopharm reports mixed Phase 3 results for Xpovio in myelofibrosis study

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones